Skip to main navigation

Theratechnologies Announces Completion of Acquisition by Future Pak. Click here to learn more.

Theratechnologies Inc. Theratechnologies Inc.

    About

  • About
    • About Us
  • Medicines & Pipeline

  • Medicines & Pipeline
    • Medicines
      • Trogarzo®
      • EGRIFTA SV®/WR™
    • Pipeline & Science
      • HIV
        • Scientific Papers
        • Patient Information
      • Expanded Access Policy
      • Grants/ISRs/IITs
  • IR Nav

  • News
  • Compliance, Ethics & Privacy

  • Compliance, Ethics & Privacy
    • Compliance
      • California Declaration
      • Report on Modern Slavery
    • Ethics
      • Code of Business Conduct and Ethics
      • Anti-Bribery and Corruption Policy
    • Privacy
  • Careers

  • Careers
  • Contact Us

  • Contact Us
  • en
    • en
    • fr
  • btn Alerts

  • Sign up for Email Alerts

Social icons

SEC Filing

IR Nav

Stock

Prices shown in CAD

Mar 30, 2026 10:10 PM EDT

IR Tools

  • Email Alerts
  • RSS Feeds

Document Details

Form
40-F/A
Filing Date
Feb 1, 2013
Document Date
Nov 30, 2011
Form Description
40-F/A
Filing Group
Other
Company
Theratechnologies Inc.
Issuer
Theratechnologies Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Headquarters

Theratechnologies inc.
2015 Peel Street, 11th Floor
Montréal, Québec
Canada H3A 1T8
Phone: 514 336-7800
Fax: 514 331-9691

Privacy

Jocelyn Lafond
Privacy Officer
privacy@theratech.com

US Headquarters

Theratechnologies U.S., Inc.
101 Hudson Street
21st Floor
Jersey City, New Jersey 07302

Main Nav

  • Home
  • About
  • Medicines & Pipeline
  • News
  • Compliance, Ethics and Privacy
  • CA Disclosure
  • Careers
  • Contact Us
©2026 - Theratechnologies Inc.

Legal Nav

  • Terms of Use
  • Privacy

Search

Theratechnologies